Federico Cappellacci*, Gian Luigi Canu, Stefano Piras, Giacomo Anedda, Pietro Giorgio Calò, Fabio Medas
Oncologie, Vol.24, No.1, pp. 35-50, 2022, DOI:10.32604/oncologie.2022.020864
- 31 March 2022
Abstract Thyroid cancer is the fifth most common cancer in the USA, with differentiated subtype accounting for more
than 95% of neoplasm. Surgery remains the mainstay of treatment, either with lobectomy or total thyroidectomy.
In the last decades, many technological innovations have been introduced in this field. The aim of this review is to
illustrate the most recent advances regarding the classical surgical approach, particularly regarding hemostatic
devices, parathyroid identification with fluorescence systems, intraoperative identification of lymph node metastases, and intraoperative neuromonitoring. More >
Login
Register
